151. Functional, Structural, and Neurotoxicity Biomarkers in Integrative Assessment of Concussions
- Author
-
Joseph C. Maroon, Eugenia V. Alexandrova, Alexander Potapov, Alicia Sufrinko, John D. Mullins, and Svetlana A. Dambinova
- Subjects
medicine.medical_specialty ,Functional impairment ,mild TBI ,neurotoxicity and neuroplasticity biomarkers ,Diagnostic accuracy ,lcsh:RC346-429 ,03 medical and health sciences ,0302 clinical medicine ,Physical medicine and rehabilitation ,Neuroimaging ,Hypothesis and Theory ,Concussion ,Mild TBI (mTBI) ,medicine ,advanced MRI sequences ,lcsh:Neurology. Diseases of the nervous system ,neuropsychological evaluations ,Neurotoxicity ,030229 sport sciences ,medicine.disease ,Return to play ,Neurology ,Symptom report ,Clinical diagnosis ,concussion ,Neurology (clinical) ,Psychology ,Neuroscience ,030217 neurology & neurosurgery - Abstract
Concussion is a complex, heterogeneous process affecting the brain. Accurate assessment and diagnosis and appropriate management of concussion are essential to ensure that athletes do not prematurely return to play or others to work or active military duty, risking re-injury. To date, clinical diagnosis relies primarily on evaluating subjects for functional impairment using instruments that include neurocognitive testing, subjective symptom report, and neurobehavioral assessments, such as balance and vestibular-ocular reflex testing. Structural biomarkers, defined as advanced neuroimaging techniques and biomarkers assessing neurotoxicity and immunoexcitotoxicity, may complement the use of functional biomarkers. We hypothesize that neurotoxicity AMPA, NMDA, and kainite receptor biomarkers might be utilized as a part of comprehensive approach to concussion evaluations, with the goal of increasing diagnostic accuracy and facilitating treatment planning and prognostic assessment.
- Published
- 2016
- Full Text
- View/download PDF